Business6 hours ago
Corbus Pharmaceuticals Presents CRB-701 Findings on Head and Neck Cancer
Corbus Pharmaceuticals Holdings, Inc. has unveiled significant insights regarding its investigational drug, CRB-701, during a recent panel discussion focused on head and neck cancer. The event...